Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Melanoma

  Free Subscription


05.07.2021

2 Ann Surg Oncol
2 BMC Cancer
1 Br J Cancer
3 Br J Dermatol
2 Cancer Res
3 Clin Cancer Res
2 J Invest Dermatol
3 Melanoma Res
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Ann Surg Oncol

  1. ASARE EA, Swami U, Stewart JH 4th
    Landmark Series on Disparities in Surgical Oncology: Melanoma.
    Ann Surg Oncol. 2021 Jun 30. pii: 10.1245/s10434-021-10273.
    PubMed         Abstract available

  2. ASARE EA, Stewart JH 4th
    ASO Author Reflections: Melanoma Killed Bob Marley and Others Too.
    Ann Surg Oncol. 2021 Jun 26. pii: 10.1245/s10434-021-10283.
    PubMed        


    BMC Cancer

  3. COEN O, Corrie P, Marshall H, Plummer R, et al
    The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma.
    BMC Cancer. 2021;21:761.
    PubMed         Abstract available

  4. MARTINI C, DeNichilo M, King DP, Cockshell MP, et al
    CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix.
    BMC Cancer. 2021;21:765.
    PubMed         Abstract available


    Br J Cancer

  5. MAIQUES O, Fanshawe B, Crosas-Molist E, Rodriguez-Hernandez I, et al
    A preclinical pipeline to evaluate migrastatics as therapeutic agents in metastatic melanoma.
    Br J Cancer. 2021 Jun 25. pii: 10.1038/s41416-021-01442.
    PubMed         Abstract available


    Br J Dermatol

  6. HARGADON KM
    The Role of Interferons in Melanoma Resistance to Immune Checkpoint Blockade: Mechanisms of Escape and Therapeutic Implications.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20608.
    PubMed         Abstract available

  7. ALTAYEB A, Dawood S, Atwan A, Mills C, et al
    Teledermoscopy: A Helpful Detection Tool for Amelanotic and Hypomelanotic Melanoma.
    Br J Dermatol. 2021 Jun 29. doi: 10.1111/bjd.20609.
    PubMed         Abstract available

  8. GAO JM, Garioch JJ, Fadhil M, Tan E, et al
    Planning slow Mohs excision margins for lentigo maligna: a retrospective nonrandomized cohort study comparing reflectance confocal microscopy margin mapping vs. visual inspection with dermoscopy.
    Br J Dermatol. 2021;184:1182-1183.
    PubMed        


    Cancer Res

  9. WHITE JR, Thompson DT, Koch KE, Kiriazov BS, et al
    AP-2alpha-mediated activation of E2F and EZH2 drives melanoma metastasis.
    Cancer Res. 2021 Jul 1. pii: 0008-5472.CAN-21-0772.
    PubMed         Abstract available

  10. IIZUKA S, Quintavalle M, Navarro JC, Gribbin KP, et al
    Serine-Threonine Kinase TAO3-Mediated Trafficking of Endosomes Containing the Invadopodia Scaffold TKS5alpha Promotes Cancer Invasion and Tumor Growth.
    Cancer Res. 2021;81:1472-1485.
    PubMed         Abstract available


    Clin Cancer Res

  11. ASHWORTH A
    ATR Inhibitors and Paclitaxel in Melanoma.
    Clin Cancer Res. 2021 Jun 25. pii: 1078-0432.CCR-21-1778.
    PubMed         Abstract available

  12. MARIN ND, Krasnick BA, Becker-Hapak M, Conant L, et al
    Memory-like differentiation enhances NK cell responses to melanoma.
    Clin Cancer Res. 2021 Jun 29. pii: 1078-0432.CCR-21-0851.
    PubMed         Abstract available

  13. LONG GV, Robert C, Butler MO, Couture F, et al
    Standard-Dose Pembrolizumab Plus Alternate-Dose Ipilimumab in Advanced Melanoma: KEYNOTE-029 Cohort 1C, a Phase 2 Randomized Study of Two Dosing Schedules.
    Clin Cancer Res. 2021 Jul 1. pii: 1078-0432.CCR-21-0793.
    PubMed         Abstract available


    J Invest Dermatol

  14. SHEINBOIM D, Parikh S, Parikh R, Menuchin A, et al
    Slow transcription of the 99a/let-7c/125b-2 cluster results in differential miRNA expression and promotes melanoma phenotypic plasticity.
    J Invest Dermatol. 2021 Jun 26. pii: S0022-202X(21)01406.
    PubMed         Abstract available

  15. CHU EY, Takeshita J, Ming ME
    Shedding Light on Disparities in Melanoma Care.
    J Invest Dermatol. 2021;141:1625-1626.
    PubMed         Abstract available


    Melanoma Res

  16. CULLEN GD, Finnes HD, Markovic SN, Volcheck GW, et al
    Successful encorafenib desensitization in a patient with recurrent metastatic melanoma.
    Melanoma Res. 2021;31:402-404.
    PubMed         Abstract available

  17. ADAMS AM, Chick RC, Vreeland TJ, Clifton GT, et al
    Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metastatic melanoma.
    Melanoma Res. 2021;31:378-388.
    PubMed         Abstract available

  18. XIAO M, Tang N, Yan Y, Li Z, et al
    Knockdown of enhancer of rudimentary homolog expression attenuates proliferation, cell cycle and apoptosis of melanoma cells.
    Melanoma Res. 2021;31:309-318.
    PubMed         Abstract available


    PLoS One

  19. MATKOVIC S, Dotlic J, Gazibara T, Maric G, et al
    Functional assessment of cancer therapy questionnaire for melanoma in the Serbian population: A factor analytic approach.
    PLoS One. 2021;16:e0253937.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: